Cancer Treatment Options, which are affordable, effective and without side effects.

World experts in Portland share the latest Trials and Studies for Cancer and Low Dose Naltexone (LDN) and for other Autoimmune Diseases. The LDN 2017 Conference – The Only Dedicated Low Dose Naltrexon

London, UK, August 22, 2017 /PressReleasePing/ - Dr Akbar Khan, MD said "The LDN conference is essential for Medical Professionals to attend. Through the dedicated research efforts of doctors around the world, LDN has been shown to be a powerful off-label therapy for the most prevalent and devastating chronic diseases including Cancer and Autoimmune Conditions. Health professionals will not learn about LDN through traditional medical conferences because LDN is a generic low cost drug. There is no motivation for the pharmaceutical industry to spend money educating doctors about this generic drug. Please attend! You will find this to be an exciting an eye-opening conference!"

Presentations include:

CANCER

The Role of Non-Cytotoxic Drugs in Cancer Management - Professor Angus Dalgleish

Broad Spectrum, Gentler Anti-Neoplastics Replacing Toxic Therapy �" Dr. Akbar Khan, MD

New Cost-Effective Treatment for cancer and Chronic, Autoimmune Diseases - Nasha Winters, ND

Using the Latest Ideas in Immunotherapy to Improve Outcomes, Survival, and Quality of Life in Cancer Management - Paul S. Anderson, NMD

Why Portland, Oregon? LDN is taught in medical schools in Portland which isn't the norm, making it the ideal location.

Aim of the conference: to help educate MD's, DO's, ND, PA-c's, Nurse Practitioners and Pharmacists in the use of LDN and to encourage further trials and studies.

CE Credits from: The American Association of Naturopathic Physicians 26 Credits and The Oregon Board of Naturopathic Medicine 27.75 Credits.

About the LDN Research Trust: The LDN Research Trust is a UK Registered Charity, established in 2004 They have helped over 41,000 people in the US to find an LDN Prescriber and actively help and support LDN Prescribers, Researchers and Pharmacists. www.ldnresearchtrust.org

Linda Elsegood or the speakers would be available for interview.

Press Passes are available upon request for the conference.

Press Contact:

Linda Elsegood

CEO

LDN Research Trust

PO 1083 Buxton Norwich NR10 5HQ UK

847 794 8046

http://www.ldn2017.com/